Please provide your email address to receive an email when new articles are posted on . Patients with advanced retinitis pigmentosa who received intravitreal optogenetics gene therapy in a phase 1/2a ...
Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) lesion site Evidence of retinal structural improvement persisted out to 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback